In-ear medical devices for acoustic therapies in tinnitus treatments, state of the art

Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus

Research interest in understanding tinnitus has increased severalfold in the last decade to find a cure for this auditory disorder. Hyperacusis can also accompany tinnitus, although the mechanisms involved in hyperacusis and tinnitus are different. Millions of people suffer from some degree of tinnitus with hearing loss. Tinnitus is believed to be a form of sensory epilepsy, spawning neuronal hyperactivity from the cochlear nucleus and inferior colliculus of the auditory brainstem region. Cannabis has been used for recreation, medicinal purposes, and served as an entheogen from time immemorial. With the current and increasing global medical and recreational cannabis legalization, there is renewed enthusiasm for the use of cannabinoid drugs, and the role of the endocannabinoid system (ECS) in several health disorders including tinnitus which is associated with COVID-19. The ECS signaling pathways have been proposed to affect the underlying pathophysiology of tinnitus. Cannabinoid receptors (CBRs) have been found in the auditory system, raising interest in ECS signaling in hearing and tinnitus. However, previous studies mostly in animal models of tinnitus did not investigate the involvement of CB2Rs but focused on CB1R-based responses, which suggested that CB1R ligands had no effect and may even be harmful and worsen tinnitus. With new molecular techniques and transgenic approaches used to dissect the complexity of the ECS, the role of ECS/CB2R neuroimmunological function in the auditory system and tinnitus is emerging. This perspective proposes the role of emerging neuroimmune crosstalk of the ECS in sound-sensing structures of the auditory system as a potential pharmacogenomic therapeutic target using cannabinoid CB2R ligands in tinnitus in the era of the COVID-19 pandemic.

Different Headphone Models Modulate Differently Alpha and Theta Brain Oscillations When Listening to the Same Sound

The frequency content of a sound changes the perception of acoustic features, but can headphones also change auditory information interpretation? Audio devices such as headphones are factors that have not been taken into consideration at studying sound perception, specifically in acoustic therapies. In particular, alternative treatments based on psychoacoustic effects could be more effective if the frequency response of headphones is found as a determining factor.This investigation, therefore, aims to study the brain response (in terms of electroencephalographic activity) produced by listening to pink noise in three different headphone models. Furthermore, not only the immediate response is studied, but the sound habituation (after daily exposure to pink noise for 30 days) is also investigated. The investigation findings reveal that headphones with a flatter frequency response provide more accurate acoustic information to the brain, what in turn, demands a larger number and a wider variety of mental resources, even after a habituation process.Clinical Relevance-This investigation establishes that audio devices are a determining factor to achieve specific psychoacoustic effects since they change the auditory information decoding at a cortical level.